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ABSTRACT: Bacteria increase their metabolic capacity via the acquisition of genetic material or by the
mutation of genes already present in the genome. Here, we explore the mechanisms and trade-offs involved
when Shewanella oneidensis, a bacterium that typically consumes small organic and amino acids, rapidly
evolves to expand its metabolic capacity to catabolize glucose after a short period of adaptation to a glucoserich environment. Using whole-genome sequencing and genetic approaches, we discovered that deletions in a
region including the transcriptional repressor (nagR) that regulates the expression of genes associated with
catabolism of N-acetylglucosamine are the common basis for evolved glucose metabolism across populations.
The loss of nagR results in the constitutive expression of genes for an Nacetylglucosamine permease (nagP)
and kinase (nagK). We demonstrate that promiscuous activities of both NagP and NagK toward glucose allow
for the transport and phosphorylation of glucose to glucose-6phosphate, the initial events of glycolysis
otherwise thought to be absent in S. oneidensis. 13C-based metabolic flux analysis uncovered that subsequent
utilization was mediated by the Entner-Doudoroff pathway. This is an example whereby gene loss and
preexisting enzymatic promiscuity, and not gain-offunction mutations, were the drivers of increased
metabolic capacity. However, we observed a significant decrease in the growth rate on lactate after adaptation
to glucose catabolism, suggesting that trade-offs may explain why glycolytic function may not be readily
observed in S. oneidensis in natural environments despite it being readily accessible through just a single
mutational event:
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The ability to utilize carbon sources is a defining feature of many bacterial species, yet it is often unclear why
a given organism cannot use more substrates than it does. In general, the catabolic potential of an organism
has become increasingly predictable from annotated genome sequences (1, 2). The reconstruction of
genomescale metabolic pathways and computational frameworks, such as flux balance analysis, that seek to
predict how a cell would grow optimally given its assumed metabolic network has been instrumental in
making such predictions (3, 4). Many of the failed predictions for substrate use emerge from the inclusion or
exclusion of reactions that are actually present (2). Another notable challenge for prediction has been
substrate transport. Broad families of transporters are easily recognizable in terms of their mechanisms (ATPdriven versus proton motive force), but substrate specificity is often either hard to determine or exhibits a fair
degree of promiscuity for alternative substrates (5). For example, essentially all free-living bacteria have
enzymatic pathways that connect glucose to the tricarboxylic acid cycle, yet many organisms cannot grow on
glucose (6). This discrepancy between metabolic predictions and experimental observations remains one of
the chief limitations of genome-scale metabolic models and, by extension, is one of the primary challenges in
predicting metabolic interactions in microbial communities, even for well-resolved metabolic interactions (2,
7–9).
Here, we consider the physiology and evolution of metabolic capacities that are immediately proximal to
what an organism can accomplish from two primary perspectives. First, what metabolic traits must evolve to
allow for the utilization of a novel compound for which only one or two enzymatic reactions are missing?
Second, does the evolution of novel compound utilization engender growth trade-offs upon other substrates,
such that this may prevent such adaptation from occurring in nature?
One critical driver in the evolution of new metabolic traits is the introduction of novel enzymes or
transporters via horizontal gene transfer (HGT). While HGT tends to occur at the highest rates between
closely related bacterial species, horizontally transferred metabolic pathways have even been observed
between the domains Archaea and Bacteria (10). These events can range from involving single genes, akin to
the acquisition of antibiotic resistance, to involving whole suites of metabolic pathways associated with a new
lifestyle, such as pathways required for single-carbon metabolism or the degradation of xenobiotic chemicals
(10–13).
A second and sometimes underappreciated process for the evolution of novel metabolism is via mutations
to genes already present in an organism (14). One hurdle can be inappropriate gene regulation, whereby the
bona fide enzymatic activity needed to use a new substrate already exists but is simply not expressed
sufficiently. A prominent example of this type of adaptation is the emergence of citrate utilization during the
course of long-term serial propagation of Escherichia coli in a minimal medium containing glucose and citric
acid (15, 16). After nearly 30,000 generations, that E. coli acquired several mutations facilitating the
constitutive expression of a citrate transporter gene (citT) (16). This mutation allows for the uptake and
catabolism of citric acid under aerobic conditions—normally a metabolism used by E. coli under anaerobic
conditions (16–18). An even more challenging scenario exists when both the regulation and the enzymatic
specificity are inappropriate. There have been multiple examples from primary catabolism and biosynthetic
reactions whereby the promiscuous activity of an enzyme— often which needed to be overexpressed in the
first place—permitted the utilization of a novel substrate (19, 20). When considering these two types of
adaptations to a new substrate, metabolic reconstruction will often include enzymes that turn out not to be
expressed, leading to a “false positive” for substrates like citrate in E. coli, but does not include promiscuous
activities, thereby generating a “false negative” for considering where changes in gene regulation can permit
growth on an apparently unusable substrate. Taken together, these examples, among many others, illustrate

that bacterial carbon utilization can be a very plastic phenotype, even in the absence of horizontal gene
transfer.
Given the plasticity in evolving novel metabolisms that has often been observed under laboratory
conditions, the question arises as to why such events have not yet occurred in nature for those systems. A
primary difference may be that experimental evolution tends to be implemented in environments for which
there is no change in substrates over time, such that there is no selective pressure to remain fit on alternative
resources (21). Because of this, mutations that increase fitness on the novel substrate but simultaneously
decrease fitness on one or more previously utilized substrates (antagonistic pleiotropy) could prevent
expansion of the organism’s niche to include the novel substrate in nature. Although there are examples
where pleiotropy during adaptation to already utilizable resources has been synergistic rather than
antagonistic (22), there are numerous other cases of antagonistic pleiotropy (23–26). What is less clear is how
often antagonistic pleiotropy is involved during the adaptation to a previously unused substrate, such that it
may present a reason why such niche expansion had not occurred in nature. To address these questions, we
examined the genetic and biochemical bases for glucose metabolism in Shewanella oneidensis, a metabolic
specialist normally unable to consume glucose.
Shewanellaceae are widely regarded as a metabolically diverse group of bacteria and are well known for
their prolific use of transition metal and organic terminal electron acceptors (27, 28). Among
Shewanellaceae, S. oneidensis possesses a narrow catabolic capacity limited to fermentation products, such as
lactate and succinate, and not carbohydrates, such as glucose, galactose, or fructose (29, 30). However, like
many other aquatic bacteria, S. oneidensis is capable of catabolizing the glucose analog Nacetylglucosamine
(GlcNAc) (31). Based on a genome-scale metabolic reconstruction of S. oneidensis, part of this limited
catabolic capacity is the result of an incomplete Embden-Meyerhof-Parnas pathway (29, 30, 32–
34). S. oneidensis lacks genes encoding phosphofructokinase; however, it does have complete
EntnerDoudoroff and pentose phosphate glycolytic pathways, suggesting that hexose metabolism should be
possible (30, 32, 33). Additionally, a recent survey of known transport mechanisms in S. oneidensis has
shown that there are only a few genes encoding a phosphotransferase system with an unknown cognate
substrate(s) and a sparse array of ATP-binding cassette carbon-uptake transporters. Most carbon transport in
S. oneidensis appears to be mediated through major facilitator superfamily (MFS) transporters, similar to that
in many pseudomonads (29, 30, 32). In all, S. oneidensis appears to have many of the core requirements for
the metabolism of complex carbon sources such as glucose, but appears to lack the early necessary steps of
transport and phosphorylation.
Recently, two distinct approaches have shown that glucose metabolism is possible in S. oneidensis. First,
Choi and coworkers demonstrated that S. oneidensis can be engineered to consume glucose under a wide
variety of growth conditions by the introduction of a glucose transporter gene (gluP) and a hexokinase gene
(glk) from Zymomonas mirabilis (35). Thus, the apparent limitations to growth on glucose in S. oneidensis are
transport and phosphorylation, consistent with metabolic modeling predictions. Second, under aerobic
laboratory conditions, S. oneidensis MR-1 has been reported to acquire the ability to utilize glucose as the
sole source of carbon and energy (36). In both of these cases, it remains unclear what the genetic and
physiological bases for hexose metabolism are and what forces, such as trade-offs, may have prevented the
wild-type strain from evolving to use glucose.

In this work, we selected for mutants of S. oneidensis capable of utilizing glucose and identified the
genetic basis across multiple populations as the repeated loss of a transcriptional repressor (nagR) that
controls the expression of enzymes involved in the metabolism of GlcNAc. We show genetically and
biochemically that glucose is transported and phosphorylated by the GlcNAc transporter (NagP) and kinase
(NagK), respectively, which are constitutively expressed due to the loss of nagR. Likewise, we found via 13C
metabolic flux measurements that glucose is oxidized through the Entner-Doudoroff pathway. Finally, we
observed significant growth and yield impairments for glucose-evolved strains when grown on lactate, which
is a preferred carbon source for S. oneidensis. This suggests that trade-offs may have prevented glucose
metabolism from emerging in S. oneidensis in its natural environment. Collectively, these findings
demonstrate that increased catabolic capacity can emerge rapidly via gene loss, a process generally associated
with the deterioration of metabolic function. Likewise, bacteria viewed as having narrow carbon substrate
ranges may often have the
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FIG 1 Emergence of the Glu phenotype is a result of losing nagR via deletion. (A) Experimental procedure
for selection of Glu mutants. (B) Growth of wild-type, Glu-1, Glu-2, and ΔnagR isolates on minimal medium
agar plates supplemented with 20 mM glucose as a carbon source at 30°C for 72 h. (C) Yields of wild-type,
Glu-1, Glu-2, and ΔnagR isolates in liquid minimal medium supplemented with 20 mM glucose after 48 h of
growth. (D) The N-acetylglucosamine utilization cluster and chromosomal regions lost, as identified by
whole-genome sequencing and analysis with the breseq pipeline. Annotations from the left: nagP, GlcNAc
permease; nagK, GlcNAc kinase; hexB, -N-acetylhexosaminidase; nagR, GlcNAc operon repressor; tnp,
ISSod1 transposase; and pilY, type IV pilus protein.

latent ability to engage in more diverse metabolisms that are mutationally accessible through just one or a few
changes.
RESULTS
Rapid evolution of glucose catabolism is mediated through the loss of nagR. To isolate S. oneidensis
mutants with evolved glucose catabolism, we serially transferred four cultures (each derived from
independent colonies) in a glucose-supplemented rich medium for approximately 20 generations. These
cultures were then screened for mutants capable of glucose catabolism on a solid minimal medium with
glucose as the sole carbon source (herein referred to as Glu). From each culture, 12 isolates were
subsequently grown in glucose minimal medium and verified as S. oneidensis by PCR and plate phenotyping.
These mutants were then passaged at a 1:256 dilution through lactate minimal medium for one growth cycle
and subsequently returned to glucose minimal medium to confirm that glucose growth was the result of a
beneficial mutation and not simply from slow phenotypic acclimation to glucose as a growth substrate. We
observed that the Glu phenotype in all 12 isolates from each of the four populations appeared to be genetic
rather than physiological based on this assay.
To find the causative beneficial mutation(s) in these mutants, we performed wholegenome sequencing of
two independently derived Glu isolates. Putative mutations were identified using the breseq sequence analysis
pipeline developed by Barrick and coworkers (37), yielding two candidate mutations by comparison with the
wild-type S. oneidensis. The most promising was a deletion spanning a chromosomal region containing
predicted open reading frames (ORFs) annotated as a type IV pilus apparatus, an NADH dehydrogenase gene,
and a transcriptional repressor (nagR) believed to be involved in regulating Nacetylglucosamine (GlcNAc)
utilization (Fig. 1D), as it was present in both sequenced isolates and was near known GlcNAc utilization
genes. Confirming the independent provenance of these two isolates, the span of the deletion differed in the
proximal end of each deletion (Fig. 1D). Examining all 48 isolates by PCR genotyping, we found that they all
contained deletions spanning nagR. Examining the

FIG 2 Loss of nagR results in constitutive expression of N-acetylglucosamine utilization genes. (A) Wildtype, Glu-1, Glu-2, and ΔnagR isolates harboring either pBRR-MCS-2 or pNagR grown on minimal medium
agar plates supplemented with 20 mM glucose and 50 g/ml kanamycin at 30°C for 72 h. (B) Green
fluorescent protein expression from the NagR-repressed hexB promoter in the wild type and Glu-1, Glu-2,
and ΔnagR mutants, as determined by measurement of emission at 520 nm and normalized to the OD600 of the
culture. Cells were grown to mid-log phase in liquid minimal medium supplemented with 20 mM DL-lactate.

novel junctions identified by breseq does not appear to indicate any strong homology that would facilitate
efficient homologous recombination. We do note that the region lost contains two copies of the ISSod1
transposon, which may have been involved in promoting the loss of this common region of DNA.
Based on the chemical structural similarity of glucose to GlcNAc, we suspected the loss of nagR and the
subsequent use of constitutively expressed GlcNAc catabolic genes as a possible source of the Glu
phenotype. To confirm this hypothesis, we deleted nagR in the wild-type background and observed the
subsequent emergence of the Glu phenotype with final yields similar to those of the evolved Glu mutants (Fig.
1C). Likewise, the complementation of nagR in either the nagR deletion strain or the evolved mutants
abolished the ability of S. oneidensis to grow on glucose (Fig. 2A). These results clearly point to the loss of
nagR as being critical for the evolved glucose catabolism.
Loss of nagR results in constitutive expression of the nag regulon. Using a green fluorescent protein
(GFP) transcriptional reporter, we found that NagR-repressed genes are constitutively expressed in Glu
mutants as well as in a synthetic nagR deletion mutant. NagR has been characterized as a LacI family
transcriptional repressor and is suspected to bind numerous DNA binding sites within the chromosomal
neighborhood of the nagR-nagP gene cluster (31, 38). Using these bioinformatics-based predictions, we

hypothesized that the loss of nagR was ultimately leading to unregulated constitutive expression of
NagRrepressed genes. To test this, we constructed a transcriptional fusion of the promoter region of hexB
(which encodes a -N-acetylhexosaminidase) to gfp in the broad-host-range vector pPROBE-gfp (39). The
promoter driving hexB has been suggested to also drive expression of the distal GlcNAc transport and
catabolic genes (38). All hexB fusion plasmid-harboring strains were grown in lactate minimal medium to
allow for the growth of the mutants and the wild type. In congruence with our suspected mechanism, we
observed 6- to 12-fold higher levels of GFP expression in the nagR and Glu mutants than in the wild type.
Interestingly, we also observed a 1.85to 1.96-fold increase in GFP expression in the synthetic nagR
background over that in

FIG 3 Expression of the N-acetylglucosamine transporter, NagP, is sufficient to allow growth on glucose.
Wild-type, ΔnagP, Glu-1 ΔnagP, and ΔnagR ΔnagP isolates harboring pBRR-MCS-2 or pNagP grown on
minimal medium agar plates supplemented with 20 mM glucose and 50 g/ml kanamycin at 30°C for 72 h. the
Glu mutants (Welch t test, P 0.001). A possible explanation is that the impaired growth on lactate (see Fig. 6;
see also Fig. S2 in the supplemental material) observed in evolved and synthetic nagR mutants altered the
rates of transcriptional initiation or the plasmid copy number, with the synthetic nagR deletion displaying the
greater effects. Regardless, these data indicate that constitutive activation of nagR-regulated genes is likely
the regulatory mechanism yielding Glu mutants.

Uptake of glucose in Glu mutants is mediated by NagP. The fundamental limitation for glucose
utilization by S. oneidensis is believed to stem from the lack of both a glucose-specific transport mechanism
and a glucokinase needed to produce glucose-6-phosphate (29). Notably, the S. oneidensis MR-1 genome
does encode a number of carbohydrate transport mechanisms (32). However, these genes have either become
pseudogenes as a result of frameshift mutations and/or insertions or do not encode for proteins functionally
capable of transporting glucose (29). Recently, it was demonstrated that these limitations can be
circumvented via heterologous expression of a glucose transporter gene (gluP) and a glucokinase gene (glk)
from Zymomonas mirabilis, allowing for growth on glucose (35); thus, supporting a model in which both
transport and glucose phosphorylation are limiting events. To understand how S. oneidensis overcomes these
limitations via the loss of nagR, we explored the role of the GlcNAc transporter (nagP) in glucose catabolism.

As previously demonstrated, the loss of nagR results in constitutive expression of genes involved in
GlcNAc uptake and catabolism, including nagP, encoding a GlcNAc permease. Based on the structural
similarity of GlcNAc and glucose, we hypothesized that NagP may allow promiscuous glucose transport and
obviate the first barrier to glucose utilization. To determine the role of NagP in facilitating glucose
catabolism, we created a nagP deletion mutant and tested its growth on glucose. We found that the loss of
nagP results in a loss of the Glu phenotype in both the spontaneous mutants and in the nagR mutant (Fig. 3).
Additionally, complementing nagP restored the growth on glucose. Interestingly, the expression of nagP in
the wild-type background (i.e., providing only a mechanism of glucose transport) was sufficient to allow for
growth on glucose. Taken together, these data show that the loss of nagR, and thus the overexpression of
nagP, is sufficient to facilitate glucose catabolism in S. oneidensis. Likewise, our observations show that one
or more enzymes must be displaying glucokinase activity to convert glucose to glucose-6-phosphate.
Glucose can be phosphorylated by the GlcNAc kinase, NagK. In addition to the transport by NagP, we
tested whether the GlcNAc kinase, NagK, was capable of converting glucose to glucose-6-phosphate. Despite
nagP expression having been sufficient for the Glu phenotype, the phosphorylation of glucose to glucose6phosphate still presented a source of uncertainty in fully characterizing glucose catabolism in Glu mutants.
Based on the genes that were found to be constitutively expressed upon the loss of nagR and that the
complementation of nagR repressed glucose catabolism, we hypothesized that the source of glucokinase
activity may be the overexpression of nagK, a GlcNAc kinase gene. To test this possibility, we

FIG 4 The kinase (NagK) of the N-acetylglucosamine pathway is capable of converting glucose to glucose6phosphate. (A) The N-acetylglucosamine pathway for conversion of GlcNAc and glucose to glucose6phosphate. (B) In vitro kinase activities of purified NagK with GlcNAc and glucose substrates and the fold
differences of activities between these substrates across the same concentrations (inset). performed kinase
activity assays with purified NagK to determine whether NagK is able to phosphorylate glucose in addition
to its known substrate, GlcNAc (Fig. 4A). We found that, across a wide range of concentrations (0.1 to 1
mM), NagK is capable of phosphorylating glucose at 3.5- to 8.4-fold lower levels of activity than for
GlcNAc (Fig. 4B). While additional kinases may phosphorylate glucose, these data strongly indicate that
NagK is capable of preparing glucose for glycolysis.

Glucose catabolism is mediated through the Entner-Doudoroff pathway. After establishing a
mechanism for the transport and phosphorylation of glucose, we sought to identify what glycolytic pathways
are used by S. oneidensis to catabolize glucose. In many bacteria, such as E. coli, there are three canonical
pathways for glucose catabolism: the Embden-Meyerhof-Parnas (EMP) pathway, the pentose phosphate (PP)
pathway, and the Entner-Doudoroff (ED) pathway. The utilization of each pathway is often variable
depending on substrate availability, on growth rate, and/or on adaptation to the environment (40– 42).
However, many bacteria lack one or more of these pathways and can rely exclusively on the EMP, PP, or ED
pathway for glycolytic activity. Despite its apparent lack of carbohydrate transport capabilities, S. oneidensis
possesses nearly all of the enzymes required for the EMP, PP, and ED pathways, with the notable exception
of phosphofructokinase. Based on genome-scale metabolic reconstruction, the lack of phosphofructokinase is

believed to result in an incomplete and inactive EMP pathway in S. oneidensis (29, 30, 33). However, there
have been no empirical results to directly support this prediction, as the possibility of a sugar kinase with
relaxed specificity toward fructose6-phosphate cannot be excluded. For instance, E. coli relies on
phosphofructokinase-1 (encoded by pfkA) for more than 90% of the conversion of fructose-6phosphate to
fructose-1,6-bisphosphate, yet it possesses a second structurally unrelated phosphofructokinase (encoded by
pfkB) that can allow for the use of the EMP pathway in pfkA mutants (43, 44).
To explore how glucose is metabolized by S. oneidensis, we performed a metabolic flux analysis based on the
distribution of 13C incorporation into protein-bound amino

FIG 5 Measured flux ratios indicated that the Entner-Doudoroff pathway is the primary pathway for glucose
catabolism. (A) The glycolytic pathways detectable by 13C-glucose labeling include the EmbdenMeyerhofParnas pathway (1), the Entner-Doudoroff pathway (2), the methylglyoxal pathway (3), and the
pentose phosphate pathway (4). (B) Measured flux ratios for major glycolytic pathways and ancillary
metabolic branch points as determined by 13C labeling and METFoR analysis. Data and associated standard
errors are from three biological replicates.

acids during growth on either single-carbon labeled [1-13C]glucose or universally labeled [U-13C]glucose as
determined by gas chromatography-mass spectrometry (45). Batch cultures of S. oneidensis were grown in
either 100% [1-13C]glucose or 20%

[U-13C]glucose (the remaining 80% of the glucose was unlabeled). Mass distributions of
13

C incorporation were used by the biochemical analysis software FiatFlux (46) to estimate the fractional

contributions to key metabolites, such as pyruvate, phosphoenolpyruvate, and serine, from the major
glycolytic pathways and the tricarboxylic acid (TCA) cycle.
An analysis of 13C incorporation during growth on [1-13C]glucose indicated carbon flux was channeled
predominantly through the ED pathway (100% 3%, 104% 3%, and 102% 2% for Glu-1, Glu-2, and ΔnagR
mutants, respectively) (Fig. 5B), as estimated from the fractions of pyruvate derived from the ED pathway
versus the PP or EMP pathways. In accordance with the predictions, S. oneidensis did not have any
appreciable flux through the EMP pathway (1% 0.57%, 0.3% 0.1%, and 0.4% 0.43% for Glu-1, Glu-2, and
ΔnagR mutants, respectively) based on the fractions of pyruvate derived from the EMP pathway. While we
cannot statistically reject trace EMP pathway usage, we suspect that these values, in conjunction with the 5%
to 8% of phosphoenolpyruvate derived from the PP pathway (based on [U-13C]glucose labeling), could be
artifacts of gluconeogenic anabolic reactions. Thus, the primary mode of glycolytic activity in S. oneidensis is
mediated through the ED pathway, consistent with observations made in other bacteria lacking
phosphofructokinase activity (47).
Emergence of glucose catabolism reduces the growth rate on lactate. To gain insight into why such
rapid evolution of glucose utilization had not occurred in nature, we tested whether there were any substantial
decreases of fitness that may have occurred as a result of Glu mutations. Adaptation to a novel environment
frequently comes after the loss of fitness or deteriorated function in other environments (25). Commonly, the
timeline for observing metabolic deterioration is hundreds or thousands of generations (22, 48). Here, we
desired to understand if any substantial loss of fitness or deterioration of function may have occurred as a
result of Glu mutations. We

FIG 6 Growth and yield trade-offs exist for glucose utilization. Growth rates (A) and yields (B) for the wild
type and the spontaneous Glu mutants Glu-1 and Glu-2 grown on GlcNAc (10 mM), glucose (10 mM), and
DL-lactate (20 mM). Data and associated 95% confidence intervals are from 8 biological replicates. *, P 0.01
versus the wild type by Wilcoxon rank sum test. examined the growth on lactate and on GlcNAc as two
representative carbon sources that could be consumed by S. oneidensis prior to the selection for Glu mutants.

We cultured wild-type and two Glu (Glu-1 and Glu-2) isolates in minimal medium containing lactate,
GlcNAc, or glucose and measured the growth rates and yields. For all cultures, no change in doubling time
was observed with growth on GlcNAc due to an adaptation to growth on glucose, and both Glu-1 and Glu-2
mutants had similar growth rates on glucose. By contrast, both Glu-1 and Glu-2 mutants had significant
decreases in the growth rates on lactate. Specifically, Glu-1 and Glu-2 mutants had 14.2% and 10.6%
decreases, respectively, in the growth rates on lactate compared with that of the wild type (Wilcoxon rank
sum test, P 0.003 and P 0.007, respectively) (Fig. 6A). Correspondingly, we also observed 10.8% and 10.3%

average decreases in yields for Glu-1 and Glu-2 mutants, respectively, compared with that of the wild type
(Wilcoxon rank sum test, P 0.00015 for both cases) (Fig. 6B). A similar trend was observed for the nagR
mutant, further implicating the loss of nagR as the genetic basis for this observed trade-off for growth on
lactate (Fig. S2). Interestingly, we did observe that the Glu-1 mutant also had an 18.4% decrease in yield on
GlcNAc compared with that of the wild type (Wilcoxon rank sum test, P 0.00015) (Fig. 6B), whereas no
significant decrease in yield on GlcNAc was observed for the Glu-2 mutant (Wilcoxon rank sum test, P 0.5)
(Fig. 6B). These data demonstrate that both growth rate and yield trade-offs exist due to mutations that allow
for growth on glucose.

DISCUSSION
In this work, we looked to explore two questions that revolve around the capacity of S. oneidensis to
evolve the ability to utilize glucose. First, what metabolic traits must evolve to facilitate this novel
metabolism? Second, are there growth trade-offs associated with the evolution of these metabolic traits that
may explain the lack of this metabolism in the organism’s natural environments? Addressing the first of these
questions, we found that a single mutational step was used repeatedly by S. oneidensis to overcome the two
fundamental limitations to hexose metabolism that are predicted by genome-scale metabolic models, namely,
transport and phosphorylation. This single mutation is the deletion of a transcriptional regulator of GlcNAc
metabolism (nagR) that resulted in constitutive expressions of nagP and nagK, encoding a transporter and
kinase, respectively. Using genetic and biochemical approaches, we found that the expression of nagP is
sufficient to facilitate glucose metabolism and that the GlcNAc transporter and kinase use glucose as a
substrate. Additionally, we dissected how glucose is metabolized by S. oneidensis after evolutionary
adaptation and observed that glucose is oxidized via the ED pathway to near exclusion, despite an intact PP
pathway and near-complete EMP pathway. Thus, it appears that altering the regulation of GlcNAc metabolic
genes and the reliance on their intrinsic enzymatic promiscuity are both required for engendering the wildtype S. oneidensis with the ability to consume glucose. Considering the second question, we discovered that
the adaptation to metabolize glucose imposes a significant fitness trade-off in the form of decreased growth
rate and yield on lactate, and for one case, a decreased yield on GlcNAc, both of which are ancestral
substrates for S. oneidensis. Taken together, these findings illustrate that changes in gene regulation and
underlying enzymatic promiscuity may be important mechanisms for increasing metabolic capacity, but that
the associated fitness trade-offs of a new metabolism may be what prevents it from emerging in natural
environments.
A more broadly framed question from these findings is why does glucose metabolism not rapidly emerge
in other metabolically restricted bacteria? Most free-living bacteria have intact anabolic pathways for
gluconeogenesis and, by extension, possess most, if not all, of the enzymes required for glucose catabolism
via either the EMP, PP, or ED pathways (6, 49). For instance, Methylobacterium extorquens AM1 (a
methylotrophic bacterium specializing in the consumption of single-carbon compounds) possesses complete
PP and ED pathways, yet is notably unable to consume glucose or other carbohydrates (50, 51). One reason
for this discrepancy may be the lack of a suitable transport mechanism. While S. oneidensis possesses a
sufficiently promiscuous transporter in the form of NagP to allow glucose uptake, M. extorquens may not
have a carbohydrate transporter with sufficiently broad specificity to facilitate the same process. Accordingly,

multiple attempts to evolve glucose utilization in wild-type M. extorquens have not been successful (C. J.
Marx and S. Stolyar, unpublished data).
Another hindrance to the rapid adaptation of bacteria to novel carbon sources is that enzymes capable of
performing the necessary promiscuous metabolic reactions may not be adequately expressed. The work by
Hall and coworkers exploring evolved -galactosidase activity in lacZ mutants of E. coli illustrates this point
(19). In a number of lactose-utilizing isolates, it was found that, while underlying mutations in the evolved
galactosidase (EbgA4C4) were sufficient for enzymatic activity toward lactose, growth on lactose was only
observed when a corresponding loss of function in the repressor of ebgAC expression (EbgR) was also
present, in so-called class I mutants (19). In these class I mutants, the loss of EbgR function resulted in the
constitutive expression of ebgAC, allowing nearly 5% of the soluble protein in E. coli to be comprised of
evolved -galactosidase and robust growth on lactose in the absence of LacZ (52). Similarly, we have found
that the underlying promiscuity of NagP and NagK toward glucose is masked by NagR repression, and only
on loss of NagR function did we observe growth on glucose. Akin to the studies performed on evolved
galactosidase, it remains to be seen what the breadth of carbon sources are that Glu mutations will facilitate in
S. oneidensis and how the activities of NagP and NagK may be shaped by subsequent selection in a glucose
environment. Thus, the presence and adequate expression of promiscuous enzymes may be key limitations to
rapid metabolic diversification in many bacteria.
Finally, if adaptation (or reversion) to glucose metabolism occurs so readily for S. oneidensis, why did
adaption to catabolize glucose not occur readily in nature? Furthermore, what could have made the loss of
glucose catabolic function beneficial in the first place (if indeed S. oneidensis was once able to consume
glucose)? The answer to these questions may be that the loss of glucose uptake afforded S. oneidensis with
improved growth on organic acids, such as lactate. From our findings, it is clear that the restoration of glucose
uptake via the loss of nagR imposes substantial trade-offs in growth rate and yield while growing on lactate.
Given the catabolic diversity in other Shewanella species and the large number of pseudogenes in
carbohydrate transporters in S. oneidensis (29), it seems quite likely that carbon-diet restriction to organic and
amino acids by S. oneidensis is a relatively new event in evolutionary terms and that the ancestor of modern
S. oneidensis may have had a more diverse catabolic capacity. By this logic, the initial loss of glycolytic
metabolism may have improved the growth rate on organic acids, while the adaptation (or reversion) to
consume glucose may have been selected against due to the reduction in growth rate (27, 53).
In this way, the current specialization of S. oneidensis may have arisen from a trade-off that produced a more
optimal phenotype on more oxidized sources of carbon that are likely in greater abundance in its
carbohydrate-poor, microaerobic aquatic environment.
Bacterial gains of metabolic function are frequently associated with the acquisition of new genetic material
via horizontal gene transfer. In our study and many others, such as those described above, it is clear that the
intrinsic, latent metabolic capacity of many bacteria is an underappreciated mechanism of expanding the
range of carbon sources that can be used. Thus, furthering our understanding of how horizontally transferred
and latent mechanisms are functionally used in natural environments will be critical to our ability to assess
the ecological roles of various bacteria and to dissect what types of metabolic interactions may be
functionally important in complex microbial communities. With this in mind, as the application of diverse
bacteria becomes more prevalent in biotechnology, the exploration of latent metabolic capacities may be a

key to expanding the possible carbon feedstocks available for use in a given process. For example, rather than
focusing on heterologous expression of transporters and pathways— which requires significant
optimization—a bacterium may already have a route for uptake and metabolism that can be readily selected
for, as we observed here.

MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. All strains of Shewanella oneidensis MR-1 and
Escherichia coli used in this work are described in Table S1 in the supplemental material. Routine culturing
of S. oneidensis and E. coli was performed in Luria-Bertani broth liquid and solid media (10 g/liter tryptone,
5 g/liter yeast extract, 5 g/liter NaCl, and 16 g/liter agar for solid medium). The growth of S. oneidensis using
glucose or DL-lactate as a carbon source at a specified concentration was carried out using a HEPES-buffered
medium similar to that described by Deutschbauer and colleagues (30 mM HEPES-KOH, 1.5 g/liter NH4Cl,
1.75 g/liter NaCl, 0.1 g/liter KCl, 0.61 g/liter MgCl2, and 0.6 g/liter NaH2PO4, pH 7.2) supplemented with
Wolfe’s vitamins and minerals (54). Conjugal matings were performed on Luria broth agar plates
supplemented with 300 M 2,6-diaminopimelic acid to facilitate the growth of
E. coli donor strains. For the selection of plasmids or chromosomal insertions, kanamycin was used at 50
g/ml or chloramphenicol was used at 10 g/ml, respectively. Sucrose counterselection was performed using
tryptone-yeast extract (TY) agar plates (10 g/liter tryptone, 5 g/liter yeast extract, 16 g/liter agar)
supplemented with 5% sucrose. All cultures were grown at 30°C, unless otherwise specified.
Isolation of glucose-utilizing mutants. Four independent colonies of strain S1419 (55) were each
inoculated into 10 ml of Luria broth supplemented with 20 mM glucose in 50-ml Erlenmeyer flasks. Cultures
were grown to saturation under well-aerated conditions (shaking at 220 rpm). Saturated cultures were then
diluted 128-fold (allowing 7 cell generations to reach saturation) and grown to saturation under the same
conditions. This procedure was repeated once more, yielding approximately 20 generations in total, and 104
dilutions of each culture were plated on glucose minimal medium agar plates.
Plates were incubated for 4 days until glucose-utilizing colonies were identified. From each of the four
populations, 12 isolates were collected (48 total) and were grown to saturation in glucose minimal medium.
These 48 isolates were then subcultured (1:256) in DL-lactate minimal medium to saturation and
subsequently subcultured (1:256) in glucose minimal medium. Lack of growth under this regime would
indicate glucose utilization may have arisen from acclimation and not from an adaptive mutation. All 48
isolates grew under these conditions, whereas S1419 did not.
Identification of mutations via whole-genome sequencing. For whole-genome sequencing, isolates from
two of the four populations were chosen. Genomic DNA was harvested by cetyltrimethylammonium bromide
(CTAB)-phenol organic extraction (56), and sequencing libraries were prepared using either Illumina TruSeq
reagents or in-house transpososome tagmentation (57). Sequencing reactions were performed on an Illumina
HiSeq2000 or MiSeq using 50-bp single-end reads or 25-bp paired-end reads, respectively. Read processing,
alignment, and mutation identification were performed using breseq version 0.21 (37). After comparison to
mutations in our wild-type strain, putative Glu mutations were verified by PCR and/or capillary DNA
sequencing. DNA sequencing reads have been deposited in the NCBI Sequence Read Archive (SRA).
Creation of knockout plasmids and mutants. All DNA oligonucleotides used in molecular cloning are
described in Table S2. Deletions of nagR and nagP were performed using an “in-out” sucrose
counterselection approach. As ColE1 and pBR322 plasmids replicate in S. oneidensis, we generated a new

suicide integration vector, pLC284a, by PCR amplifying the cat-sacB cassette from pCM433 (58) and
ligating this with the MluI fragment of pKNOCK-Km (59) containing the RP4 transfer origin and R6K
replication origin. The nagR and nagP deletion plasmids, pLC315 and pLC311, respectively, were created by
PCR amplifying two regions flanking nagR or nagP followed by isothermal DNA assembly (60) with a
pLC284a plasmid that had been linearized with NotI and SalI. These plasmids were harbored in E. coli strain
WM3064 to facilitate high-frequency conjugal transfer to S. oneidensis recipients. Primary insertion of these
plasmids into nagR or nagP was identified by selection on Luria agar supplemented with chloramphenicol,
and excision was selected for on TY agar supplemented with 5% sucrose. Deletions in sucrose-resistant
mutants were verified by PCR, checking for both the expected deletion and the loss of the pLC284a
backbone.
Complementation of nagR and nagP was accomplished by cloning nagR and nagP, with their respective
ribosome binding sites and start codons, into the lacZ coding region of pBBR-MCS-2 (61), allowing for
constitutive expression from the lac promoter. DNA fragments containing nagP and nagR flanked by EcoRI
and XbaI restriction sites were generated by PCR amplification and were then cloned into the EcoRI and
XbaI sites of pBBR-MCS-2 to produce plasmids pLC319 (pNagP) and pLC321 (pNagR), in that order.
Measurement of NagR-dependent transcriptional regulation. Changes in NagR-dependent
transcriptional repression were determined using a green fluorescent protein gene (gfp) fusion to the promoter
preceding the hexB gene (Fig. 1). The hexB promoter region was PCR amplified and cloned into the KpnI and
EcoRI restriction sites of the promoter fusion vector pPROBE-gfp (39) to yield pLC307. To measure GFP
expression, cells carrying pPROBE-gfp or pLC307 were grown in minimal medium containing 20 mM DLlactate to an optical density at 600 nm (OD600) of 0.3 followed by fluorescence measurement using a Tecan
Safire2 plate reader with an excitation of 488/5 nm and emission detection at 520/5 nm.
Fluorescence values were blanked using pPROBE-gfp as a baseline followed by normalization to the OD600 of
the sample to correct for differences in cell number.
Purification of NagK and kinase activity assays. NagK was purified using nickel(II)-nitrilotriacetic acid
(NiNTA) affinity chromatography. The nagK coding region lacking a start codon was PCR amplified and
cloned into the BamHI and PstI sites of plasmid pQE80L to produce pLC318, containing an in-frame fusion
of 6 histidine codons to the N-terminal region of nagK.
For expression of 6His-NagK, pLC318 was transformed into the protein expression E. coli strain ER2523
(New England BioLabs). The transformant was cultured overnight in Luria broth and subcultured 1:100 in
250 ml of fresh Luria broth and grown with vigorous aeration in a baffled 1-liter Erlenmeyer flask at 37°C.
Once the OD600 of the culture reached 0.8, protein expression was induced by introducing isopropyl--D1thiogalactopyranoside to the culture at a final concentration of 1 mM. The induced culture was further
incubated for 3 h and harvested by centrifugation at 6,000 g at 4°C. The resulting cell pellet was washed once
with tris-buffered saline (TBS; 50 mM Tris-HCl, 150 mM NaCl, pH 7.5), was pelleted at 6,000 g, and then
was frozen at75°C. Pellets were then resuspended in TBS supplemented with 0.1% Triton X-100, Roche
complete protease inhibitor cocktail (Roche), and CelLytic B (Sigma-Aldrich) at a ratio of 5 ml per gram of
cell mass. Lysis proceeded on ice for 15 min, followed by centrifugation at 20,000 g for 1 h to remove cell
debris. Clarified lysates were then passed through a 0.22-m filter and loaded onto a 1-ml Ni-NTA–agarose
column that had been preequilibrated with 10 bed volumes of TBS. Loaded Ni-NTA–agarose was washed
with TBS supplemented with 20 mM imidazole to reduce nonspecific protein binding. Finally, 6His-NagK
was eluted with 2 ml of TBS supplemented with 200 mM imidazole and dialyzed against 2 liters of TBS in 4
exchanges. The purity of 6His-NagK was determined to be 95% based on gel staining with Coomassie
brilliant blue R-250 (Acros).

Enzyme assays with 6His-NagK were performed in kinase reaction buffer (40 mM Tris-HCl, 20 mM
MgCl2, 0.1 mg/ml bovine serum albumin) using the ADP-Glo kinase assay (Promega) per the manufacturer’s
specifications. To each reaction, 20 g of 6 His-NagK was added with various concentrations of ATP or
substrate. Reaction progress was measured via luminescence using a BioTek Cytation 3 multimode plate
reader in Perkin-Elmer 384-well AlphaPlates. Data analysis and plotting were performed using R and ggplot2
(62).
Measurement of flux ratios. Metabolic flux ratios were determined using the procedure described by
Zamboni and coworkers with minor modifications (45). Glu strains of S. oneidensis were grown in 10 ml of
minimal medium supplemented with either 100% [1-13C]glucose or a mix of 20% [U-13C]glucose/80%
glucose (20 mM glucose total, Cambridge Isotope Laboratory) to mid-log phase (OD600, 0.3). Cells were
harvested by centrifugation and were washed twice followed by resuspension in 500 l of 6 M HCl. The cell
resuspension was then heated to 100°C for 8 h followed by evaporation of the HCl under nitrogen flow for 4
h to yield dried cell hydrolysate. The dried hydrolysate was then gently resuspended in 100 l of
dimethylformamide. Subsequently, 40 l of the crude hydrolysate was derivatized with an equal volume of
tertbutyldimethylsilylN-methyltrifluoroacetamide with 1% tert-butyldimethylchlorosilane at 85°C for 1 h.
The derivatized hydrolysate was injected into a Shimadzu QP2010 gas chromatograph/mass spectrometer
(GC/MS) equipped with a 30-m Rxi-1ms column (Restek). The injection source was 230°C and the column
was heated from 160°C to 310°C at 20°C min1 during each experimental run. Metabolic flux ratios for key
metabolites were determined by METAFoR analysis using the MATLAB FiatFlux analysis package (46). The
data presented are the results from three biological replicates.
Measurement of growth rates and yields. Growth rates and yields were determined based on
measurements of OD600 over time using an automated culturing system (63, 64). Cells were grown in minimal
medium containing either lactate, glucose, or GlcNAc. Cultures were grown to saturation on these substrates
followed by a 1:256 dilution into fresh medium, and 640 l of each dilution was transferred to independent
wells of a 48-well microtiter plate. Plates were incubated at 30°C and the OD600 was measured every 2 h for
48 h. OD data were corrected to media-only controls, and growth rates and yields were calculated using the
CurveFitter software package. Each reported growth rate and yield value is the mean from 8 biological
replicates.
Accession number(s). Sequencing data from this work have been deposited in the Sequence Read Archive
under accession numbers SRR5359626, SRR5359627, and SRR5359628.
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